Mylan (NASDAQ:MYL) is an American pharmaceutical company. It first publicly traded on the OTC Markets and subsequently traded on the NYSE and NASDAQ.
For its first five years on the NYSE, it traded below $5 and back in 1989 the stock was trading for as little as $1.13. However, it was on the ascent in the 2000s and hit an intraday peak of $76.69 in April of 2015. From low to high the stock increased 6687%.
Recently, headlines surrounding the price hike of its EpiPen have damaged the company’s stock price considerably. It’s currently trading at $37.05.
*Prices correct as of 28/11/16